KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial

NCT05635591 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

9

Enrollment

OTHER

Sponsor class

Conditions

EBV-associated Haematologic Neoplasms

Interventions

BIOLOGICAL: Autologous monocyte - derived DCs pulsed with EBV antigen

Sponsor

Tongji Hospital

Collaborators

[object Object]